{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:03:48Z","timestamp":1790553828229,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.euroneuro.2005.10.005","type":"journal-article","created":{"date-parts":[[2005,11,29]],"date-time":"2005-11-29T12:47:26Z","timestamp":1133268446000},"page":"281-287","source":"Crossref","is-referenced-by-count":75,"title":["A double-blind, randomised, controlled clinical trial of acetyl-l-carnitine vs. amisulpride in the treatment of dysthymia"],"prefix":"10.1016","volume":"16","author":[{"given":"R.","family":"Zanardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Smeraldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2005.10.005_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1176\/ajp.140.1.11","article-title":"Dysthymic disorder: psychopathology of proposed chronic depressive subtypes","volume":"140","author":"Akiskal","year":"1983","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.10.005_bib2","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.euroneuro.2005.10.005_bib3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00004850-200111000-00001","article-title":"Faster response on amisulpride 50 mg versus sertraline 50\u2013100 mg in patients with dysthymia or double depression: a randomised, double-blind, parallel group study","volume":"16","author":"Amore","year":"2001","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.euroneuro.2005.10.005_bib5","first-page":"405","article-title":"Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years","volume":"50","author":"Barrett","year":"2001","journal-title":"J. Fam. Pract."},{"key":"10.1016\/j.euroneuro.2005.10.005_bib4","first-page":"131","article-title":"Effects of acetyl-l-carnitine (ALC) treatment in dementia: a multicentric, randomized, double-blind study","volume":"3","author":"Battistin","year":"1989","journal-title":"New Trends Clin. Neuropharmachol."},{"issue":"6","key":"10.1016\/j.euroneuro.2005.10.005_bib6","first-page":"355","article-title":"Effect of acetyl-l-carnitine on geriatric patients suffering from dysthymic disorders","volume":"X","author":"Bella","year":"1990","journal-title":"Int. J. Clin. Pharm. Res."},{"issue":"4","key":"10.1016\/j.euroneuro.2005.10.005_bib7","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1600-0447.1991.tb05533.x","article-title":"5-HT2 receptor antagonism in dysthymic disorder: a double-blind placebo-controlled study with ritanserin","volume":"83","author":"Bersani","year":"1991","journal-title":"Acta Psychiatr. Scand."},{"issue":"1","key":"10.1016\/j.euroneuro.2005.10.005_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000026556","article-title":"Amisulpride versus amineptine and placebo for the treatment of dysthymia","volume":"39","author":"Boyer","year":"1999","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.euroneuro.2005.10.005_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00004850-200201000-00004","article-title":"Efficacy and safety of amisulpride 50 mg versus paroxetine 20 mg in major depression: a randomised, double-blind, parallel group study","volume":"17","author":"Cassano","year":"2002","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.euroneuro.2005.10.005_bib11","first-page":"163","article-title":"Amelioration of the depression of HIV-infected subjects with l-acetyl-carnitine therapy","volume":"1","author":"De Simone","year":"1988","journal-title":"J. Drug Dev."},{"issue":"5","key":"10.1016\/j.euroneuro.2005.10.005_bib12","doi-asserted-by":"crossref","first-page":"1172S","DOI":"10.1093\/ajcn\/76.5.1172S","article-title":"Efficacy and tolerability of oral and intramuscular S-adenosyl-l-methionine 1,4-butanedisulfonate (SAMe) in the treatment of major depression: comparison with imipramine in 2 multicenter studies","volume":"76","author":"Delle Chiaie","year":"2002","journal-title":"Am. J. Clin. Nutr."},{"issue":"1","key":"10.1016\/j.euroneuro.2005.10.005_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00019442-200501000-00009","article-title":"Randomized, double-blind, placebo-controlled trial of fluoxetine treatment for elderly patients with dysthymic disorder","volume":"13","author":"Devanand","year":"2005","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.10.005_bib14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/(SICI)1520-6394(1999)10:2<68::AID-DA5>3.0.CO;2-3","article-title":"Dysthymic disorder: treatment with mirtazapine","volume":"10","author":"Dunner","year":"1999","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.euroneuro.2005.10.005_bib19","first-page":"155","article-title":"Laevo-acetylcarnitine treatment of senile depression","volume":"27","author":"Fulgente","year":"1990","journal-title":"Clin. Trials J."},{"key":"10.1016\/j.euroneuro.2005.10.005_bib20","first-page":"101","article-title":"Evaluation of the effects of l-acetylcarnitine on senile patients suffering from depression","volume":"16","author":"Garzya","year":"1990","journal-title":"Drugs Exp. Clin. Res."},{"key":"10.1016\/j.euroneuro.2005.10.005_bib21","first-page":"333","article-title":"Acetyl-l-carnitine in aged subjects with major depression: clinical efficacy and effects on the circadian rhythm of cortisol","volume":"2","author":"Gecele","year":"1991","journal-title":"Dementia"},{"key":"10.1016\/j.euroneuro.2005.10.005_bib22","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1176\/ajp.150.8.1169","article-title":"A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia","volume":"150","author":"Hellerstein","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.10.005_bib23","doi-asserted-by":"crossref","first-page":"845","DOI":"10.4088\/JCP.v60n1207","article-title":"Venlafaxine in the treatment of dysthymia: an open-label study","volume":"12","author":"Hellerstein","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.10.005_bib24","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1176\/appi.ajp.157.9.1436","article-title":"Double-blind comparison of sertraline, imipramine and placebo in the treatment of dysthymia: effects on personality","volume":"157","author":"Hellerstein","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.10.005_bib25","first-page":"93","article-title":"Adding group psychotherapy to medication treatment of dysthymia: a randomised perspective pilot study","volume":"10","author":"Hellerstein","year":"2001","journal-title":"J. Psychother. Pract. Res."},{"key":"10.1016\/j.euroneuro.2005.10.005_bib26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00004714-200106000-00012","article-title":"Bupropion sustained-release for the treatment of dysthymic disorder: an open-label study","volume":"21","author":"Hellerstein","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2005.10.005_bib28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00004714-199104000-00003","article-title":"Pharmacotherapy of dysthymia: a review","volume":"11","author":"Howland","year":"1991","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2005.10.005_bib29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1001\/archpsyc.1994.03950010008002","article-title":"Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey","volume":"51","author":"Kessler","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.10.005_bib30","unstructured":"International Conference on Harmonisation Steering Committee, 1998. Note for Guidance on Statistical Principles in Clinical Trials. London, England: International Conference of Harmonization; March 1998. ICH Topic E9 (CPMP\/ICH\/363\/96)."},{"issue":"Suppl 3","key":"10.1016\/j.euroneuro.2005.10.005_bib31","doi-asserted-by":"crossref","first-page":"S329","DOI":"10.1016\/S0924-977X(97)00065-5","article-title":"Antidepressant efficacy in the treatment of dysthymia","volume":"7","author":"Invernizzi","year":"1997","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.euroneuro.2005.10.005_bib32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0327(96)00103-6","article-title":"Amisulpride versus imipramine and placebo in dysthymia and major depression","volume":"43","author":"Lecrubier","year":"1997","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.euroneuro.2005.10.005_bib33","first-page":"CD001130","article-title":"A comparison of drugs versus placebo for the treatment of dysthymia","author":"Lima","year":"2000","journal-title":"Cochrane Database Syst. Rev."},{"issue":"Suppl 4","key":"10.1016\/j.euroneuro.2005.10.005_bib35","first-page":"S9","article-title":"Dopaminergic deficit and the role of amisulpride in the treatment of mood disorders","volume":"17","author":"Montgomery","year":"2002","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.euroneuro.2005.10.005_bib36","article-title":"Action of acetyl-l-carnitine in association with mianserine on depressed people","volume":"III","author":"Nasca","year":"1989","journal-title":"New Trends Clin. Neuropharmachol."},{"issue":"13","key":"10.1016\/j.euroneuro.2005.10.005_bib37","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2165\/00023210-200317130-00001","article-title":"Diagnosis and treatment of dysthymia in children and adolescents","volume":"17","author":"Nobile","year":"2003","journal-title":"CNS Drugs"},{"issue":"6","key":"10.1016\/j.euroneuro.2005.10.005_bib38","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2165\/00023210-199912060-00005","article-title":"Amisulpride a review of its clinical potential in dysthymia","volume":"12","author":"Noble","year":"1999","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.euroneuro.2005.10.005_bib39","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1017\/S1461145702003085","article-title":"A double-blind, randomized parallel-group, efficacy and safety study of intramuscular S-adenosyl-l-methionine 1,4-butanedisulphonate (SAMe) versus imipramine in patients with major depressive disorder","volume":"5","author":"Pancheri","year":"2002","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2005.10.005_bib40","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/sj.mp.4000805","article-title":"Acetyl-carnitine physical\u2013chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression","volume":"5","author":"Pettegrew","year":"2000","journal-title":"Mol. Psychiatry"},{"issue":"11","key":"10.1016\/j.euroneuro.2005.10.005_bib41","doi-asserted-by":"crossref","first-page":"821","DOI":"10.4088\/JCP.v61n1103","article-title":"Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression","volume":"61","author":"Ravindran","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.10.005_bib42","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0165-0327(01)00327-5","article-title":"A comparison of paroxetine and amisulpride in the treatment of dysthymic disorder","volume":"70","author":"Rocca","year":"2002","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.euroneuro.2005.10.005_bib43","first-page":"CD004047","article-title":"A comparison of active drugs for the treatment of dysthymia","author":"Silva de Lima","year":"2003","journal-title":"Cochrane Database Syst. Rev."},{"issue":"suppl.3","key":"10.1016\/j.euroneuro.2005.10.005_bib44","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0924-9338(96)85189-3","article-title":"Amisulpride versus fluoxetine in dysthymia: preliminary results of double-blind comparative study","volume":"11","author":"Smeraldi","year":"1996","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.10.005_bib45","series-title":"Data on File Sigma-Tau Industries","article-title":"Blocking of GABA activated chloride currents by acetylcholine and acetylcarnitine: a patch-clamp research on colliculus superior cultures of the rat","author":"Standhart","year":"1998"},{"key":"10.1016\/j.euroneuro.2005.10.005_bib46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0028-3908(85)90094-2","article-title":"Stereospecific effect of acetyl carnitine on spontaneous activity of brainstem neurones and their responses to acetyl choline and serotonin","volume":"24","author":"Tempesta","year":"1985","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2005.10.005_bib47","first-page":"417","article-title":"l-Acetylcarnitine in depressed elderly subjects. A cross-over study vs. placebo","volume":"13","author":"Tempesta","year":"1987","journal-title":"Drugs Exp. Clin. Res."},{"key":"10.1016\/j.euroneuro.2005.10.005_bib48","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archpsyc.1996.01830090023004","article-title":"A placebo-controlled, randomised clinical trial comparing sertraline and imipramine for the treatment of dysthymia","volume":"53","author":"Thase","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.10.005_bib49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1192\/bjp.170.4.345","article-title":"Controlled efficacy study of fluoxetine in dysthymia","volume":"170","author":"Vanelle","year":"1997","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.10.005_bib50","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00004850-199707000-00001","article-title":"Moclobemide and imipramide in chronic depression (dysthymia): an international double-blind, placebo-controlled trial","volume":"12","author":"Versiani","year":"1997","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2005.10.005_bib51","first-page":"341","article-title":"l-Acetylcarnitine in depressed elderly patients","volume":"62","author":"Villardita","year":"1984","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.euroneuro.2005.10.005_bib53","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1176\/ajp.145.7.815","article-title":"The epidemiology of dysthymia in five communities: rates, risks, comorbidity and treatment","volume":"145","author":"Weissman","year":"1988","journal-title":"Am. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.euroneuro.2005.10.005_bib52","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/jama.284.12.1519","article-title":"Treatment of dysthymia and minor depression in primary care: a randomized controlled trial in older adults","volume":"284","author":"Williams","year":"2000","journal-title":"Jama"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X05001574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X05001574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T05:20:12Z","timestamp":1554700812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X05001574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0924977X05001574"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2005.10.005","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}